University of Dundee

Molecular Medicine

Short Code: 
MM

Drug Discovery Unit and McLean Lab formalise agreement with Pfizer Inc. to research potential new therapies for the treatment of Cystic Fibrosis

The University of Dundee has entered into a Research Program Agreement with Pfizer Inc. to jointly conduct research that may lead to potential novel treatments for Cystic Fibrosis.
 
The project will be carried out as part of Pfizer’s Rare Disease Consortium and builds on a program of research within the laboratory of Professor Irwin McLean, Head of Molecular Medicine at Dundee, and the University’s Drug Discovery Unit.
 

"Red, scaly and itching skin caused by defective protease regulation: from murine models to Netherton syndrome"

Alain Hovnanian is full professor of Genetics and Dermatology at the new IMAGINE Institute for Genetic diseases at Necker hospital for sick children in Paris. He runs a translational clinic on genetic skin diseases of children and adults. He heads the molecular diagnostic group for genodermatosis and is the director of an INSERM research team on “Genetic skin diseases: from molecular mechanisms to therapy ».

"Clinical implications of genetic discoveries in skin diseases"

 
 
About the lecture:
This annual Named Lecture is supported by the Schwartz Foundation, Salt Lake City, who sponsor research into the causes of and treatments for inherited skin disease.  It would be most appreciated if you could take the time to attend. Dr Mary Schwartz, an honorary graduate from Dundee, has funded skin disease research programmes in Dundee since 2004.
 
Wine reception outside the lecture theatre at 5pm - everyone welcome. 
 

Postdoctoral Research Assistant: Next Generation Sequencing Facility Manager

We are seeking a Researcher maintain and facilitate the running of the Genomic Sequencing Unit (GSU), the University of Dundee’s high-throughput sequencing facility. The candidate will be based at the College of Life Sciences, University of Dundee and will be responsible for the smooth operation and organisation of the facility, with tasks including project implementation and management, sample processing and running and maintenance of the sequencing instrumentation. This post is available until July 2017.

“Cutting-edge microscopy in mice and man: quantitative approaches to immunological and structural composition including mast cell recruitment in the skin”

Philip Tong is the current Dean’s Fellow in Dermatology at the University of Sydney. He completed his PhD at the Centenary Institute under Professor Wolfgang Weninger where he combines his expertise in intravital multiphoton microscopy, flow cytometry as well as transgenic murine models to investigate the immunological and structural composition of skin in health and disease. His recent work has been published in Nature Immunology, Journal of Investigative Dermatology and British Journal of Dermatology.

Next-Generation Sequencing Research Technician

We are seeking an experienced molecular biologist with proven skills in RNA and DNA manipulation, and preferably a working knowledge of next-generation sequencing (NGS) technologies (e.g. Illumina), to join The Genomic Sequencing Unit (GSU), the University of Dundee’s next generation sequencing facility. The NGS Technician will be based at the College of Life Sciences, University of Dundee and process users’ samples for genome re-sequencing, genome de novo sequencing, RNA sequencing, chromatin immunoprecipitation and other NGS applications.

Pages